These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 15963495

  • 1. Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets.
    Asplund Persson A, Zalavary S, Lindström E, Whiss PA, Bengtsson T, Grenegård M.
    Eur J Pharmacol; 2005 Jul 11; 517(3):149-57. PubMed ID: 15963495
    [Abstract] [Full Text] [Related]

  • 2. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM, Brenna KJ, Colman RW, Sheth SB.
    Thromb Haemost; 2002 May 11; 87(5):873-9. PubMed ID: 12038792
    [Abstract] [Full Text] [Related]

  • 3. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1559-67. PubMed ID: 15041473
    [Abstract] [Full Text] [Related]

  • 4. Synergistic inhibition of thrombin-induced platelet aggregation by the novel nitric oxide-donor GEA 3175 and adenosine.
    Grenegård M, Gustafsson MC, Andersson RG, Bengtsson T.
    Br J Pharmacol; 1996 Aug 15; 118(8):2140-4. PubMed ID: 8864553
    [Abstract] [Full Text] [Related]

  • 5. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 6. Characterisation of GEA 3175 on human platelets; comparison with S-nitroso-N-acetyl-D,L-penicillamine.
    Asplund Persson AK, Palmér L, Gunnarsson P, Grenegård M.
    Eur J Pharmacol; 2004 Aug 02; 496(1-3):1-9. PubMed ID: 15288569
    [Abstract] [Full Text] [Related]

  • 7. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH, Cheng JT, Teng CM.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):158-67. PubMed ID: 16112105
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC, Huang WH, Shiau CY, Lee AR, Chou TC.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):32-7. PubMed ID: 16457809
    [Abstract] [Full Text] [Related]

  • 9. Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry.
    Kageyama K, Mizobe T, Nozuchi S, Hiramatsu N, Nakajima Y, Aoki H.
    J Anesth; 2004 Feb 17; 18(2):107-12. PubMed ID: 15127258
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
    Martinez A, Salas E, Radomski A, Radomski MW.
    Med Sci Monit; 2001 Feb 17; 7(4):646-51. PubMed ID: 11433190
    [Abstract] [Full Text] [Related]

  • 11. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML, Hamm HE.
    J Pharmacol Exp Ther; 2007 Aug 17; 322(2):778-88. PubMed ID: 17525299
    [Abstract] [Full Text] [Related]

  • 12. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase.
    Paul S, Feoktistov I, Hollister AS, Robertson D, Biaggioni I.
    Mol Pharmacol; 1990 Jun 17; 37(6):870-5. PubMed ID: 2359405
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N, Magid KS, Shaw CA, Webb DJ, Megson IL.
    Biochem Biophys Res Commun; 2000 Dec 20; 279(2):412-9. PubMed ID: 11118301
    [Abstract] [Full Text] [Related]

  • 14. Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels.
    Lindgren SH, Andersson TL, Vinge E, Andersson KE.
    Acta Physiol Scand; 1990 Oct 20; 140(2):209-19. PubMed ID: 2176433
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems.
    Corell T, Pedersen SB, Lissau B, Moilanen E, Metsä-Ketelä T, Kankaanranta H, Vuorinen P, Vapaatalo H, Rydell E, Andersson R.
    Pol J Pharmacol; 1994 Oct 20; 46(6):553-66. PubMed ID: 7542520
    [Abstract] [Full Text] [Related]

  • 16. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
    Bani D, Bigazzi M, Masini E, Bani G, Sacchi TB.
    Lab Invest; 1995 Nov 20; 73(5):709-16. PubMed ID: 7474945
    [Abstract] [Full Text] [Related]

  • 17. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC, Liao CH, Chang YW, Liou JT, Day YJ.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1364-73. PubMed ID: 19426675
    [Abstract] [Full Text] [Related]

  • 18. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.
    Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, Trovati M.
    Thromb Res; 2002 Jan 01; 105(1):71-8. PubMed ID: 11864710
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of platelet adhesion to collagen by cGMP-elevating agents.
    Wu CC, Ko FN, Teng CM.
    Biochem Biophys Res Commun; 1997 Feb 13; 231(2):412-6. PubMed ID: 9070290
    [Abstract] [Full Text] [Related]

  • 20. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG, Pyatakova NV, Khropov YV, Ovchinnikov IV, Makhova NN, Severina IS.
    Biochemistry (Mosc); 2000 Apr 13; 65(4):457-62. PubMed ID: 10810184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.